Foresite Capital Management VI
Foresite Capital Management VI reported 23 stocks worth $643M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CGON (26.2%), ALMS (18.6%) and SPTX (6.0%). Compared with Q1 2026, the fund opened new positions in SPTX, PBLS and BEAM, added to CGON, DNLI and CLDX and sold out of OKUR.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  CGON CG Oncology Inc | $168M | 26.2% | 2.4M | +148K (+7%) | 7 of 7 | |
| 2 |  ALMS Alumis Inc | $120M | 18.6% | 4.2M | No change | 7 of 7 | |
| 3 |  SPTX Seaport Therapeutics Inc | $38.7M | 6.0% | 1.8M | New position | 1 of 7 | |
| 4 |  DNLI Denali Therapeutics Inc | $35.9M | 5.6% | 1.4M | +187K (+15%) | 4 of 7 | |
| 5 |  CLDX Celldex Therapeutics Inc | $32.7M | 5.1% | 880K | +564K (+178%) | 2 of 7 | |
| 6 |  AGIO Agios Pharmaceuticals Inc | $29.1M | 4.5% | 785K | +260K (+50%) | 3 of 7 | |
| 7 |  CRVS Corvus Pharmaceuticals Inc | $27.4M | 4.3% | 1.8M | No change | 7 of 7 | |
| 8 |  PBLS Parabilis Medicines Inc Com | $27.3M | 4.3% | 999K | New position | 1 of 7 | |
| 9 |  GHRS GH Research PLC | $25.3M | 3.9% | 940K | +625K (+198%) | 2 of 7 | |
| 10 |  JBIO Jade Biosciences Inc | $19.7M | 3.1% | 887K | +567K (+177%) | 2 of 7 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CENTESSA PHARMACEUTICALS PLC | $54.2M | 1.4M |
 OKUR Onkure Therapeutics Inc | $6M | 1.4M |
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Foresite Capital Management VI 13F FAQ
What does Foresite Capital Management VI own?
Foresite Capital Management VI reported 23 stocks worth $643M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CGON (26.2%), ALMS (18.6%) and SPTX (6.0%). The table above lists every position in the filing (the top 10 without an account).
What did Foresite Capital Management VI buy and sell in Q2 2026?
Compared with Q1 2026: 8 new positions, 6 added to, 0 trimmed and 2 sold out. New positions include SPTX, PBLS and BEAM. It sold all of OKUR.
When will Foresite Capital Management VI file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Foresite Capital Management VI's portfolio worth?
The Q2 2026 filing reports $643M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.